![Andrew Griffiths](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Andrew Griffiths is the founder of HiFiBiO Inc., Design Pharmaceuticals, Inc. He is currently a Director at Cmed Clinical Research Services Ltd.
He was previously a Senior Vice President at ICON Clinical Research, Inc., a Principal at Abbott Laboratories and Boots Pharmaceuticals.
He was also the Chief Operating Officer at Cmed Group Ltd.
from 2004 to 2014.
Andrew Griffiths active positions
Companies | Position | Start |
---|---|---|
HiFiBiO Inc.
![]() HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology HiFiBiO Inc. develops and manufactures pharmaceutical products. It specializes in antibodies, that mobilize the human immune system to combat cancer, autoimmune disorders, and other unmet medical needs. The company was founded by Liang Schweizer, Fred Dom, Andrew Griffiths, David Weitz, Bradley Bernstein, J?r?me Bibette, and Robert Nicol and is headquartered in Paris, France. | Founder | - |
Cmed Clinical Research Services Ltd.
![]() Cmed Clinical Research Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Alten SA, Cmed Clinical Research Services Ltd. is a clinical research organization that provides full or FSP services to biotech and pharma companies for their clinical trials. Founded in 1999, the company is based in Horsham, UK. Cmed is a technology-led CRO with specialty expertise in oncology, cell and gene therapy, rare diseases, data science, and analytics. The British company provides a unique clinical trial project management model where independent professionals work alongside leads and experts to improve the quality of clinical trial data. Cmed supports projects in autoimmune disease, women's health, and other areas. | Director/Board Member | 23/10/2005 |
Former positions of Andrew Griffiths
Companies | Position | End |
---|---|---|
Design Pharmaceuticals, Inc.
![]() Design Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Design Pharmaceuticals, Inc. harnesses nature's chemistry to develop breakthrough therapeutics. The company is based in Cambridge, MA. The company uses engineering-inspired biotechnologies to redesign the process of small molecule-based drug discovery and development, saving time and costs. The company's platform is based on ultrahigh-throughput technologies that biomine and test drug-like molecules from nature at unprecedented speed and scale on hundreds of GPCR targets simultaneously. Design Pharmaceuticals' cell-free biosynthesis eliminates the inherent limitations of traditional chemistry or using platforms based on live production strains, further accelerating lead compound optimization. The company's business model aims to build a continuously growing portfolio of joint development and license agreements with pharma partners. The company was founded by Dirk Löffert, Cosmas Giallourakis, Marnix Medema, Rob Nicol, Noah W. Palm, Michael Jewett, Andrew Griffiths. Dirk Löffert has been the CEO since incorporation. | Founder | - |
ABBOTT LABORATORIES | Corporate Officer/Principal | - |
ICON Clinical Research, Inc.
![]() ICON Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Clinical Research, Inc. provides research and consulting services. It services include clinical research, biometrics, interactive technologies, laboratory, clinical pharmacology and consulting services. The company was founded by John Climax and Ronan Lambe in 1990 and is headquartered in North Wales, PA | Corporate Officer/Principal | - |
Boots Pharmaceuticals | Corporate Officer/Principal | - |
Cmed Group Ltd.
![]() Cmed Group Ltd. Miscellaneous Commercial ServicesCommercial Services Cmed Group Ltd. provides clinical research services to pharmaceutical and biotechnology companies. Its services include functional based clinical services, regulatory, consulting and product development, data and analytics, medical services, and clinical operations and study start-up services. The company was founded by David Connelly in 2000 and is headquartered in Horsham, the United Kingdom. | Chief Operating Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ABBOTT LABORATORIES | Health Technology |
Private companies | 6 |
---|---|
ICON Clinical Research, Inc.
![]() ICON Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services ICON Clinical Research, Inc. provides research and consulting services. It services include clinical research, biometrics, interactive technologies, laboratory, clinical pharmacology and consulting services. The company was founded by John Climax and Ronan Lambe in 1990 and is headquartered in North Wales, PA | Commercial Services |
Cmed Group Ltd.
![]() Cmed Group Ltd. Miscellaneous Commercial ServicesCommercial Services Cmed Group Ltd. provides clinical research services to pharmaceutical and biotechnology companies. Its services include functional based clinical services, regulatory, consulting and product development, data and analytics, medical services, and clinical operations and study start-up services. The company was founded by David Connelly in 2000 and is headquartered in Horsham, the United Kingdom. | Commercial Services |
HiFiBiO Inc.
![]() HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology HiFiBiO Inc. develops and manufactures pharmaceutical products. It specializes in antibodies, that mobilize the human immune system to combat cancer, autoimmune disorders, and other unmet medical needs. The company was founded by Liang Schweizer, Fred Dom, Andrew Griffiths, David Weitz, Bradley Bernstein, J?r?me Bibette, and Robert Nicol and is headquartered in Paris, France. | Health Technology |
Cmed Clinical Research Services Ltd.
![]() Cmed Clinical Research Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Alten SA, Cmed Clinical Research Services Ltd. is a clinical research organization that provides full or FSP services to biotech and pharma companies for their clinical trials. Founded in 1999, the company is based in Horsham, UK. Cmed is a technology-led CRO with specialty expertise in oncology, cell and gene therapy, rare diseases, data science, and analytics. The British company provides a unique clinical trial project management model where independent professionals work alongside leads and experts to improve the quality of clinical trial data. Cmed supports projects in autoimmune disease, women's health, and other areas. | Commercial Services |
Design Pharmaceuticals, Inc.
![]() Design Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Design Pharmaceuticals, Inc. harnesses nature's chemistry to develop breakthrough therapeutics. The company is based in Cambridge, MA. The company uses engineering-inspired biotechnologies to redesign the process of small molecule-based drug discovery and development, saving time and costs. The company's platform is based on ultrahigh-throughput technologies that biomine and test drug-like molecules from nature at unprecedented speed and scale on hundreds of GPCR targets simultaneously. Design Pharmaceuticals' cell-free biosynthesis eliminates the inherent limitations of traditional chemistry or using platforms based on live production strains, further accelerating lead compound optimization. The company's business model aims to build a continuously growing portfolio of joint development and license agreements with pharma partners. The company was founded by Dirk Löffert, Cosmas Giallourakis, Marnix Medema, Rob Nicol, Noah W. Palm, Michael Jewett, Andrew Griffiths. Dirk Löffert has been the CEO since incorporation. | Commercial Services |
Boots Pharmaceuticals |
- Stock Market
- Insiders
- Andrew Griffiths